MapLight Therapeutics Inc (MPLT) Unusual Options Activity Today

Checking MPLT unusual options activity helps you spot when traders are making outsized bets on MapLight Therapeutics Inc before the broader market catches on. MapLight Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor MPLT unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching MPLT unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking MPLT unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and MPLT unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease.

Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.

Catalysts rarely arrive without a footprint, and MPLT unusual options activity is often where that footprint shows up first. Our scanner tracks MapLight Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at MPLT unusual options volume on the call side or chasing put sweeps, MapLight Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.